Risk factors for symptomatic vascular events in giant cell arteritis: a study of 254 patients with large-vessel imaging at diagnosis

被引:9
|
作者
de Mornac, Donatienne [1 ]
Agard, Christian [1 ]
Hardouin, Jean-Benoit [2 ,3 ,4 ]
Hamidou, Mohamed [1 ]
Connault, Jerome [1 ]
Masseau, Agathe [1 ]
Espitia-Thibault, Alexandra [1 ]
Artifoni, Mathieu [1 ]
Ngohou, Chan [5 ]
Perrin, Francois [6 ]
Graveleau, Julie [6 ]
Durant, Cecile [1 ]
Pottier, Pierre [1 ]
Neel, Antoine [1 ]
Espitia, Olivier [1 ]
机构
[1] CHU Nantes, Dept Internal Med, 1 Pl Alexis Ricordeau, F-44093 Nantes, France
[2] Nantes Univ, UMR 1246 SPHERE, INSERM, Nantes, France
[3] Tours Univ, Tours, France
[4] Nantes Univ Hosp, Methodol & Biostat Platform, Nantes, France
[5] Nantes Univ Hosp, Dept Med Informat, Nantes, France
[6] St Nazaire Hosp, Dept Internal Med, St Nazaire, France
关键词
aortitis; giant cell arteritis; large-vessel imaging; risk factors; vascular event; COMPLICATION AORTIC-ANEURYSM; CARDIOVASCULAR-DISEASE; TEMPORAL ARTERITIS; POPULATION; INFLAMMATION; DISSECTION; METHOTREXATE; MORTALITY; STENOSIS; PET/CT;
D O I
10.1177/1759720X211006967
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To identify factors associated with vascular events in patients with giant cell arteritis (GCA). Methods: We performed a retrospective study of GCA patients diagnosed over a 20-year-period, who all underwent vascular imaging evaluation at diagnosis. Symptomatic vascular events were defined as the occurrence of any aortic event (aortic dissection or symptomatic aortic aneurysm), stroke, myocardial infarction, limb or mesenteric ischemia and de novo lower limbs arteritis stage 3 or 4. Patients with symptomatic vascular event (VE+) and without were compared, and risk factors were identified in a multivariable analysis. Results: Thirty-nine (15.4%) of the 254 included patients experienced at least one symptomatic vascular event during follow-up, with a median time of 21.5 months. Arterial hypertension, diabetes, lower limbs arteritis or vascular complication at diagnosis were more frequent in VE+ patients (p < 0.05), as an abnormal computed tomography (CT)-scan at diagnosis (p = 0.04), aortitis (p = 0.01), particularly of the descending thoracic aorta (p = 0.03) and atheroma (p = 0.03). Deaths were more frequent in the VE+ group (37.1 versus 10.3%, p = 0.0003). In multivariable analysis, aortic surgery [hazard ratio (HR): 10.46 (1.41-77.80), p = 0.02], stroke [HR: 22.32 (3.69-135.05), p < 0.001], upper limb ischemia [HR: 20.27 (2.05-200.12), p = 0.01], lower limb ischemia [HR: 76.57 (2.89-2027.69), p = 0.009], aortic atheroma [HR: 3.06 (1.06-8.82), p = 0.04] and aortitis of the descending thoracic aorta on CT-scan at diagnosis [HR: 4.64 (1.56-13.75), p = 0.006] were independent predictive factors of a vascular event. Conclusion: In this study on GCA cases with large vessels imaging at diagnosis, aortic surgery, stroke, upper or lower limb ischemia, aortic atheroma and aortitis of the descending thoracic aorta on CT-scan, at GCA diagnosis, were independent predictive factors of a vascular event.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients
    de Boysson, Hubert
    Daumas, Aurelie
    Vautier, Mathieu
    Parienti, Jean-Jacques
    Liozon, Eric
    Lambert, Marc
    Samson, Maxime
    Ebbo, Mikael
    Dumont, Anael
    Sultan, Audrey
    Bonnotte, Bernard
    Manrique, Alain
    Bienvenu, Boris
    Saadoun, David
    Aouba, Achille
    AUTOIMMUNITY REVIEWS, 2018, 17 (04) : 391 - 398
  • [32] Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently?
    de Boysson, Hubert
    Liozon, Eric
    Lambert, Marc
    Dumont, Anael
    Boutemy, Jonathan
    Maigne, Gwenola
    Silva, Nicolas Martin
    Ly, Kim Heang
    Manrique, Alain
    Bienvenu, Boris
    Aouba, Achille
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (08): : 992 - 995
  • [33] Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica
    Unizony, S.
    Arias-Urdaneta, L.
    Miloslavsky, E.
    Arvikar, S.
    Khosroshahi, A.
    Keroack, B.
    Stone, J. R.
    Stone, J. H.
    ARTHRITIS CARE & RESEARCH, 2012, 64 (11) : 1720 - 1729
  • [34] Different Patterns and Specific Outcomes of Large-Vessel Involvements in Giant Cell Arteritis
    de Boysson, Hubert
    Liozon, Eric
    Espitia, Olivier
    Daumas, Aurelie
    Vautier, Mathieu
    Lambert, Marc
    Parienti, Jean-Jacques
    Manrique, Alain
    Saadoun, David
    Ly, Kim Heang
    Agard, Christian
    Aouba, Achille
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [35] Different patterns and specific outcomes of large-vessel involvements in giant cell arteritis
    de Boysson, Hubert
    Liozon, Eric
    Espitia, Olivier
    Daumas, Aurelie
    Vautier, Mathieu
    Lambert, Marc
    Parienti, Jean-Jacques
    Granel, Brigitte
    Dumont, Anael
    Sultan, Audrey
    Manrique, Alain
    Saadoun, David
    Ly, Kim Heang
    Agard, Christian
    Aouba, Achille
    JOURNAL OF AUTOIMMUNITY, 2019, 103
  • [36] Large-vessel giant cell arteritis after COVID-19 vaccine
    Mejren, A.
    Sorensen, C. M.
    Gormsen, L. C.
    Tougaard, R. S.
    Nielsen, B. D.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2022, 51 (02) : 154 - 155
  • [37] Large-vessel imaging in patients with giant cell arteritis with scalp involvement: A commentary on giant cell arteritis associated with scalp, tongue or lip necrosis in a French multi-center case control study
    Montes, Daniel
    Bohrer, Nicholas E.
    Warrington, Kenneth J.
    Koster, Matthew J.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 68
  • [38] Risk of Large Vessel Complications in Patients with Giant Cell Arteritis, a Population-based Study
    Elfishawi, Mohanad
    Kaymakci, Mahmut
    Achenbach, Sara
    Crowson, Cynthia
    Kermani, Tanaz
    Weyand, Cornelia M.
    Koster, Matthew
    Warrington, Kenneth
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4765 - 4767
  • [39] CRANIAL-LIMITED AND LARGE-VESSEL GIANT CELL ARTERITIS: PRESENTING FEATURES AND OUTCOME
    Tomelleri, A.
    Campochiaro, C.
    Sartorelli, S.
    Farina, N.
    Baldissera, E.
    Dagna, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 674 - 675
  • [40] Large-vessel giant cell arteritis Fever of unknown origin in a patient with a prosthetic valve
    Coeman, Mathieu
    De Pauw, Michel
    ACTA CARDIOLOGICA, 2013, 68 (05) : 529 - 530